Skip to content
GLP-1 Desk
Menu
Dispatch #3Editorial

Ondra Health

Near-rock-bottom pricing paired with brand access and 50-state reach — a value standout a budget-first reader may rank #1.

Visit Ondra HealthEditorial — no commercial relationship.
Semaglutide
$93/mo
Tirzepatide
$166/mo
Coverage
All 50 states
Brand-name
Yes

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency94/100
State access96/100
Molecule range90/100
Onboarding speed85/100
Support responsiveness83/100
Licensing & trust90/100

What the Desk likes

  • Among the lowest disclosed prices on the board
  • Brand-name access available
  • Nationwide 50-state coverage
  • LegitScript-verified operator

Where points come off

  • Injectable only — no oral route
  • Newer brand without a long support history

The Desk's briefing — A−

Best for: Cost-conscious patients who still want brand-name capability and nationwide coverage.

Ondra Health ranks #3 of 25 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Pricing and verification reflect Ondra Health's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Ondra Health's site. Not medical advice; see our disclosure.

← Back to The Desk